Free Newsletter
Researcher nabs $1M Gotham Prize for cancer idea
A professor at the California Institute of Technology is walking away with the $1 million Gotham Prize for an original approach to killing cancer cells. Alexander Varshavsky proffered the idea of a targeted molecular device that could enter a cell, examine it for DNA deletions specific to cancer and killing it if it meets the right profile.
"(It) involves, in a nutshell, the finding of a genuine Achilles Heel of cancer cells, i.e., their potentially vulnerable feature that won't change during tumor progression," said Varshavsky, who won the 2000 Lasker prize for the discovery of the gene ubiquitin.
The Gotham Prize is the brainchild of two hedge fund managers who wanted to reward original thinking for cancer research while highlighting the flat federal funding that has been provided to the NIH under the Bush administration. They teamed with Dr. Gary Curhan of Harvard Medical School to pick the winner.
- read the article in the Wall Street Journal
Related Articles:
Hedge fund managers dangle million-dollar research prize. Report
Research groups angry as NIH funding stays flat. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: